Drug Resistance Updates

Journal Title：Drug Resistance Updates

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.

*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease

*Describes emerging technologies and therapies, particularly those that overcome drug resistance

*Emphasises common themes in microbial and cancer research

《耐药性更新》是一份双月刊，其中包含关于传染病和癌症耐药性重要发展以及克服耐药性的新药和策略的发人深省的评论。

它涵盖了耐药性的基础研究和临床方面，涉及分子生物学、生物化学、细胞生物学、药理学、微生物学、临床前治疗学、肿瘤学和临床医学等多种学科。

文章由该领域的领导者应编辑的邀请撰写，并在发表前经过同行评审。文章清晰、易读、最新，适合多学科读者，并包括示意图和其他插图，传达文章的主要观点。目标是突出最近的增长领域并对其进行透视。

*肿瘤学和传染病临床和基础耐药性研究的专家评论

*描述新兴技术和疗法，特别是那些克服耐药性的技术和疗法

*强调微生物和癌症研究中的共同主题

Drug Resistance Updates创刊于1998年，由Churchill Livingstone出版商出版，收稿方向涵盖医学 - 药学全领域，在行业领域中学术影响力很大，属于国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于一流期刊，建议关注此刊。平均审稿速度 约稿?周期不定 ，影响因子指数15.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。